Training bioengineers to improve cardiovascular health
Bioengineering Cardiovascular Training Grant (BCTG)
This study is all about training PhD students in bioengineering to create new tools and treatments for heart diseases, helping to improve how we detect and manage these conditions for better health outcomes.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10892189 on NIH RePORTER |
What this research studies
The Bioengineering Cardiovascular Training Grant (BCTG) program focuses on training PhD students in bioengineering to address cardiovascular diseases, which are a leading cause of death in the US. This program combines various disciplines such as engineering, chemistry, and physiology to develop innovative diagnostic and therapeutic technologies. Students will engage in collaborative research that aims to enhance early detection and management of cardiovascular conditions, ultimately improving patient outcomes. The training prepares graduates for careers in both academia and industry, fostering advancements in cardiovascular health.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals with cardiovascular diseases or those at high risk for developing such conditions.
Not a fit: Patients with non-cardiovascular related health issues may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for cardiovascular diseases, enhancing the quality of life for patients.
How similar studies have performed: Previous research in bioengineering and cardiovascular health has shown promising results, indicating that this approach has the potential for significant advancements.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Regnier, Michael — University of Washington
- Study coordinator: Regnier, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.